欢迎访问ProbeChem中文网站，英文网站请访问www.probechem.com
    英文 |     中文

产品咨询: sales@probechem.com
订购: order@probechem.com

首页-小分子抑制剂&激动剂-Others-Other Targets-DH20931
DH20931

Chemical Structure : DH20931

CAS No.: 1629992-28-4

加入收藏

DH20931 (DH-20931)

货号: PC-25458Not For Human Use, Lab Use Only.

DH20931 is a first-in-class, potent small-molecule agonist of Ceramide Synthase 2 (CerS2) with activation constant (Kact) of 16.54 nM, exhibits potent, broad-spectrum, and receptor-independent antitumor activity in vitro and in vivo.

规格 价格 库存 数量
50 mg Get quote
100 mg Get quote
250 mg Get quote
获取报价单
* 请选择数量再加入购物车
 or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

    生物&药学活性

    DH20931 is a first-in-class, potent small-molecule agonist of Ceramide Synthase 2 (CerS2) with activation constant (Kact) of 16.54 nM, exhibits potent, broad-spectrum, and receptor-independent antitumor activity in vitro and in vivo.
    DH20931 exhibits the significant growth inhibitory effects on both triple-positive and triple-negative human breast cancer cell lines with IC50 in the range of 0.3-3.9 uM.
    DH20931 potently inhibits the viability of wild-type 4T1 cells, but CERS2-knockout cells.
    DH20931 exerts its cytotoxic effects by directly activating CerS2 and driving the overproduction of pro-apoptotic VLCCs.
    DH20931 inhibits breast cancer growth in vitro and in vivo, independent of hormone receptor status.
    DH20931 induces ER stress through the ATF4 pathway in a CerS2-dependent manner.
    DH20931 promotes a novel CerS2-IP3R1 interaction, enhances ER-mitochondria proximity, and triggers mitochondrial Ca²⁺ overload.
    DH20931 induces robust apoptosis in breast cancer cells in a CerS2-dependent manner.

    物理化学性质&存储条件

    分子量 368.86
    分子式 C21H21ClN2O2
    外观性状 Solid
    CAS No.
    储存条件
    固体粉末
    -20°C 12 个月; 4°C 6 个月
    配置液
    -80°C 6 个月; -20°C 6 个月
    Shipping
    Solubility

    10 mM in DMSO
    Chemical Name/SMILES

    3,13-dimethoxy-5,6,10,11-tetrahydroimidazo[4,3-a:5,1-a']diisoquinolin-7-ium chloride

    参考文献

    1. Zajac-Kaye M, et al. bioRxiv [Preprint]. 2025 Aug 21:2025.08.15.670525.

    2. Jaiswal AS, et al. Bioorg Med Chem Lett. 2014 Oct 15;24(20):4850-3.

    备案号：沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    联系我们 sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    询单

    • *产品名称:
    • *姓名:
    • *邮箱:
    • *公司名称:
    • *询单数量:
    • *国籍:
    • 询单信息: